Brighthouse Financial, Inc. (NASDAQ: BHF) said this morning it has entered into a definitive agreement to be acquired by Aquarian Capital in an all‑cash deal valuing the company at approximately $4.1 billion, or $70.00 per share. The transaction would take the U.S. life insurer and annuity provider private and is expected to close in 2026, pending shareholder and regulatory approvals.
Key takeaways
- Price & premium: $70.00 per share in cash; ~37% premium versus BHF’s “unaffected” closing price on January 27, 2025, and ~37.7% above the 90‑day VWAP as of Nov. 5, 2025. Business Wire
- Structure: Brighthouse will operate as a standalone entity within Aquarian’s portfolio; name, brand, and Charlotte HQ remain, and CEO Eric Steigerwalt will continue to lead the company.
- Financing: Aquarian said the merger is backed by committed financing and is not subject to a financing condition; there will be no incremental debt at Aquarian’s insurance businesses or at Brighthouse.
- Capital snapshot (Q3 prelim.): Brighthouse canceled its Q3 call but reiterated it will release results after the close today, and provided prelim metrics: $5.4B total adjusted capital, combined RBC ratio 435%–455%, and $1.0B holding‑company liquid assets.
- Market reaction: BHF shares spiked ~26% premarket after the announcement. As of publication, shares were trading in the mid‑$60s intraday, leaving an ~6.25% spread to the $70 offer—typical of deals awaiting approvals.
Deal details and timeline
Under the definitive merger agreement, Aquarian will acquire all outstanding BHF common shares for $70 in cash. Preferred stock will remain outstanding with the same terms and dividends, and outstanding junior subordinated debentures and senior notes will also remain outstanding as obligations of Brighthouse following closing. The board unanimously approved the agreement and will recommend shareholders vote in favor. Closing is targeted for 2026, subject to shareholder, antitrust, and insurance regulatory approvals.
Why it matters
The deal highlights continuing private‑capital interest in U.S. insurers—businesses prized for predictable, premium‑driven cash flows. Aquarian, which counts Mubadala among its backers, is the latest to expand in retirement‑focused insurance, a sector also pursued by large alternative‑asset managers. Financial Times reporting indicates Aquarian intends to maintain current leadership and tilt the product mix toward fixed‑ and index‑linked annuities over time.
Capital and liquidity (what Brighthouse disclosed today)
Brighthouse canceled the Q3 2025 earnings call originally scheduled for Friday, Nov. 7, but said it still plans to issue the earnings release and financial supplement after today’s close. Preliminary statutory figures show total adjusted capital of $5.4B, a combined RBC ratio between 435% and 455%, and $1.0B in holding‑company liquid assets. For context, management has previously pointed to a 400%–450% RBC target range in normal market conditions.
What changes for customers, employees, and bondholders
- Customers & distribution: Brighthouse says it will continue to operate under the Brighthouse name with the same products and distribution—notably its Shield® annuity franchise and retirement‑income offerings. Operations remain in Charlotte.
- Debt & preferreds:No change to the terms or status of Brighthouse’s existing preferred shares and notes upon closing.
Market picture (today)
BHF jumped sharply after the news—Reuters cited a roughly 26% premarket pop—and has been active through the session with elevated volume. At mid‑session the stock traded around the mid‑$60s, with an intraday high in the mid‑$66s and a low near the low‑$50s earlier in the day. That price implies an approximately 6.25% discount to the $70 offer, reflecting time to close and regulatory risk that typically remain in announced M&A.
Who’s advising whom
Aquarian’s advisors include RBC Capital Markets (financial) and Skadden, Arps (legal), with actuarial support from Milliman and Oliver Wyman. Brighthouse is advised by Wells Fargo and Goldman Sachs (financial) and Debevoise & Plimpton (legal), with Milliman as actuarial advisor.
What to watch next
- Shareholder vote and subsequent state insurance and antitrust approvals.
- The Q3 2025 earnings release and financial supplement after the close today for color on capital and sales momentum.
- Any regulatory filings (proxy/SEC 8‑K) that provide the merger agreement and further details.
Sources: Official transaction and capital disclosures from Business Wire/Brighthouse & Aquarian; market and context reporting from Reuters and Financial Times.
Editor’s note: This article is for information only and not investment advice.
